-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
BIT 2022 Pre-Conference Interview
Humanized Mouse Model 2.
0: Efficacy and Safety Evaluation Platform for Dual Antibiotics
BIT 2022 5th Realistic Antibody Drug In-depth Focus Summit will be heldHumanized Mouse Model 2.
0: Efficacy and Safety Evaluation Platform for Dual Antibiotics
in Shanghai on September 8-9.
BIT 2022 Dr.
Jieling Yang, Technical Strategy Manager of BIT 2022 5th Realistic Antibody Drug Deep Focus Summit, Jackson Aite Biotechnology (Beijing) Co.
, Ltd
Jackson Aite Booth Number: A12Sweep, Twist!
Good gifts are here!
Scan the QR code below and follow us!
Good gifts are here!
Scan the QR code below and follow us!
Click on the form link and fill it out, and exchange the submission page for a Gacha token at jackson aite booth (A12) to participate in the live raffle!
The following is an interview with Dr.
Yang Jieling by the Organizing Committee
Yang Jieling by the Organizing Committee
Q What are the highlights of humanized mice with immune system in the development of bispecific antibody drugs? It is that all targets on these cells are human-derived and can be mainly used for pharmacodynamic and drug safety studies Mainly cytokine storm (CRS) research on the application of Q PBMC immune system humanized mouse model is one
of the animal models commonly used in dual-antibody drug research.
For the two most common problems in this type of model, GvHD and donor differences, does JAX have any suggestions or solutions? Donor differences are an unavoidable problem in humanized mice because this is a natural difference
in the population.
Q Dual antibodies based on NK cells are also at
the forefront of research and development.
The initial CD34+ humanized mouse model generally lacked NK cell subset differentiation, resulting in mouse strains
that later stabilized expression of IL-15.
Please tell us more about JAX's NSG-IL15
.
Q China's biopharmaceutical industry is developing rapidly, and the field of tumor immunity is only one of the corners
.
If you look at the industry as a whole, can you tell us about what unique disease models or resources Jackson Labs can have to support drug discovery? Our disease model can be said to cover all areas of disease research, such as neurodegenerative disease models, autoimmune disease models, rare disease models, and so on
。 In addition, in order to better serve Chinese users, JAX has also set up a joint venture subsidiary In China, JAX has also set up a joint venture subsidiary Jackson Aite Biotechnology Co.
, Ltd.
in China, in addition to helping everyone more conveniently obtain imported JAX mice, Jackson Aite will also produce high-quality JAX mice locally, covering common inbred mice, severe immunodeficiency strainSGTM and humanized mouse strains.
It is hoped that Chinese users can obtain high-quality mouse models
in a more convenient and economical way.